title: Potential adverse effects to the retina of cancer therapy targeting pyruvate kinase M2.
authors.affiliation: South Australian Institute of Ophthalmology, University of Adelaide , South Australia , Australia.
authors.forename: Soo Khai
authors.initials: SK
authors.lastname: Ng
authors.forename: John P M
authors.initials: JP
authors.lastname: Wood
authors.forename: Glyn
authors.initials: G
authors.lastname: Chidlow
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Peet
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Casson
mesh_terms: D006019:Glycolysis; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism; D019344:Lactic Acid / Q000096:biosynthesis; D009369:Neoplasms / Q000378:metabolism / Q000628:therapy*; D011770:Pyruvate Kinase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D034741:RNA, Small Interfering / Q000502:physiology; D012160:Retina / Q000378:metabolism
chemical_list: D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D034741:RNA, Small Interfering; D019344:Lactic Acid; D011770:Pyruvate Kinase